RRIGX | TRTIX | RRIGX / TRTIX | |
Total Expense Ratio | 1.33 | 0.68 | 196% |
Annual Report Gross Expense Ratio | 1.33 | 0.68 | 196% |
Fund Existence | 23 years | 10 years | - |
Gain YTD | 31.302 | 31.529 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 500000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.2B | 16.2B | 100% |
Annual Yield % from dividends | 1.60 | 2.18 | 74% |
Returns for 1 year | 24.30 | 24.83 | 98% |
Returns for 3 years | 86.90 | 90.02 | 97% |
Returns for 5 years | 96.03 | 100.81 | 95% |
Returns for 10 years | 89.69 | 98.84 | 91% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HELX | 30.62 | 0.36 | +1.20% |
Franklin Genomic Advancements ETF | |||
BAMG | 36.92 | 0.09 | +0.26% |
Brookstone Growth Stock ETF | |||
RSMR | 21.45 | N/A | N/A |
FT Vest U.S. Equity Equal Weight Buffer ETF - March | |||
SQQQ | 17.45 | -0.04 | -0.23% |
ProShares UltraPro Short QQQ | |||
LRGE | 80.17 | -0.19 | -0.24% |
ClearBridge Large Cap Growth Select ETF |